In our study, EC patients had lower G-CSF plasma levels; however, the median values of both cancer and control groups remained relatively low compared to the case reports with advanced type 2 EC, evaluated via the commercially available ELISA kit [54]. This evidence concerns the gene CSF3 and cancer.